Clinical trial
Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention
NCT00162357 is registered in ClinicalTrials.gov with Lantheus Medical Imaging as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cardiolite-406; A Phase IV Open-Label, Randomized, Multi-Center Trial To Evaluate The Ability of Cardiolite Stress MPI to Detect Asymptomatic Restenosis in Diabetic Patients Who Have Undergone Percutaneous Coronary Intervention
- Lead sponsor
- Lantheus Medical Imaging
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- December 31, 2005
- Enrollment
- 106 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.